These Alzheimer's tests raise many important issues that patients and their physicians should carefully consider before requesting or administering them.

There is no single blood test for Alzheimer's. Rather, these tests look for biomarkers —biological signs that Alzheimer's may ...

Cognitively healthy older adults with high levels of a biomarker called p-tau217 in their blood had an estimated 38% greater chance of developing early signs of dementia over five years, a new study ...

A p-tau217 blood test predicted a 78% chance of cognitive decline within 10 years for symptom-free adults with very high levels of the biomarker.

Atypical Alzheimer's disease treatment eligibility is blocked for up to 85% of patients by a cognitive test never designed ...

In Alzheimer's disease, amyloid plaques form in the brain, followed by threadlike structures made of the protein tau. Both changes have toxic effects on the brain's nerve cells years before dementia ...

Add Yahoo as a preferred source to see more of our stories on Google. More than 50 GP surgeries across central and northern Scotland are participating in the initiative, known as Bringing Alzheimer's ...

New findings could expand access to earlier screening opening the door to faster answers for families long overlooked in ...

Another biomarker may spot future risk sooner, but experts say more evidence is needed before it reshapes screening.

Data presented at the Alzheimer’s Association International Conference 2026 shows the PrecivityAD2 blood test improves the accuracy of diagnosis in primary and specialty care settings.

The ability to diagnose Alzheimer's decades earlier could be a step closer with a new blood test set for clinical trials ...

Add Yahoo as a preferred source to see more of our stories on Google. A simple blood test detecting a specific protein linked to Alzheimer's disease may help predict future cognitive decline in older ...